Insider · CIK 0001217598

RENSCHLER MARKUS MD

Reports to the SEC for 2 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001217598

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-04	Cyteir Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+6,304 sh	$1.69	+$10.7K	1,103,661
2024-03-04	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−6,304 sh	—	—	220,648
2024-02-29	Cyteir Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+12.6K sh	$1.69	+$21.3K	1,094,820
2024-02-29	Cyteir Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2,537 sh	$1.20	+$3,044.4	1,097,357
2024-02-29	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−12.6K sh	—	—	226,952
2024-02-29	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2,537 sh	—	—	0
2023-12-11	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−6,304 sh	—	—	239,559
2023-12-11	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2,536 sh	—	—	2,537
2023-11-20	Cyteir Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+6,304 sh	$1.69	+$10.7K	1,079,677
2023-11-20	Cyteir Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2,536 sh	$1.20	+$3,043.2	1,082,213
2023-11-20	Cyteir Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+56.7K sh	$1.69	+$95.9K	1,045,473
2023-11-20	Cyteir Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+27.9K sh	$1.20	+$33.5K	1,073,373
2023-11-20	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−56.7K sh	—	—	245,863
2023-11-20	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−27.9K sh	—	—	5,073
2023-02-03	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+303K sh	—	—	302,600
2023-01-13	Cyteir Therapeutics, Inc.A Award	Director, President and CEO	AAward	+5,000 sh	$1.49	+$7,450	983,736
2022-12-21	Cyteir Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+106K sh	$1.03	+$110K	948,299
2022-12-21	Cyteir Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+30.4K sh	$1.20	+$36.5K	978,736
2022-12-21	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−106K sh	—	—	0
2022-12-21	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−30.4K sh	—	—	32,973
2022-02-22	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+106K sh	—	—	106,200
2005-06-03	PHARMACYCLICS INCEmployee Stock Option (right to buy)A Award	VP, Oncology Clinical Dev.	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Mar 54
RENSCHLER MARKUS MD0001209191-24-004438
SEC(opens sec.gov)
Dec 144
RENSCHLER MARKUS MD0001209191-23-058609
SEC(opens sec.gov)
Nov 224
RENSCHLER MARKUS MD0001209191-23-056426
SEC(opens sec.gov)
Feb 74
RENSCHLER MARKUS MD0001209191-23-007494
SEC(opens sec.gov)
Dec 234
RENSCHLER MARKUS MD0001209191-22-062627
SEC(opens sec.gov)

Companies

Address

128 SPRING ST, BUILDING A, SUITE 510

LEXINGTON, MA, 02421